Live Breaking News & Updates on Ndivior

Stay informed with the latest breaking news from Ndivior on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Ndivior and stay connected to the pulse of your community

Earnings Update: Indivior PLC (LON:INDV) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

The investors in Indivior PLC 's ( LON:INDV ) will be rubbing their hands together with glee today, after the share...

United-kingdom , Earnings-per-share , Nalyst-estimates , Evenue-estimates , Ndivior , Rowth-estimates , Onsensus-estimates , Rice-target , Esults-announcement ,

Fresh blow for London market as drug maker joins exodus to New York

Indivior, the British drug maker, is to ditch its primary listing on the London Stock Exchange for New York in the latest blow to the Square Mile.

London , City-of , United-kingdom , Frankfurt , Brandenburg , Germany , New-york , United-states , British , Smurfit-kappa , Centers-for-disease , Reckitt-benckiser

Indivior Settles Patent Dispute With Teva Unit

Indivior PLC (INDV, INDV.L) announced that its subsidiaries Indivior Inc. and Indivior UK, entered into a settlement agreement with Actavis Laboratories UT, a unit of Teva Pharmaceuticals, to resolve patent disputes regarding Actavis's Abbreviated New Drug Application for generic buprenorphine and naloxone sublingual film.

United-states , More-such-health-news , Indivior-inc , Teva-pharmaceuticals , Indivior-united-kingdom , Actavis-laboratories , Abbreviated-new-drug-application , Patent , Eva , Ndivior ,

Great week for Indivior PLC (LON:INDV) institutional investors after losing 22% over the previous year

Key Insights Given the large stake in the stock by institutions, Indivior's stock price might be vulnerable to their...

United-kingdom , Seas-capital , Indivior-plc , Nstitutional-investors , Nstitutional-ownership , Nstitutions , Ndivior , Hareholder , Nalyst-forecasts , Hare-prices ,

Unveiling Indivior PLC (INDV)'s Value: Is It Really Priced Right? A Comprehensive Guide

A deep dive into the valuation of Indivior PLC (INDV)

Gf-value-of-indivior , Growth-of-indivior , Gurufocus-value , Drug-manufacturers , Earnings-per-share , Year-financials , Gurufocus-high-quality-low-capex , Indivior-plc , F-value , Ndivior , Ompany-39s-financial

Click Expands to Substance Use Disorder With Indivior Digital Therapeutics Pact

Digital therapeutics developer Click Therapeutics is partnering with Indivior to develop a mobile app for substance use disorder. Indivior is now Click’s third development partner, following deals with Boehringer Ingelheim and Otsuka Pharmaceutical.

Boehringer-ingelheim , David-klein , Medcity-news , Pear-therapeutic , Weight-loss , Besity , Verweight , Diabetes , Massachusetts , Medical-devices , Obesity , Startups

Indivior to pay $30 million to settle health plans' Suboxone claims

Indivior has agreed to pay $30 million to settle a class action lawsuit filed in a U.S. court by health plans accusing the drugmaker of illegally suppressing generic competition for its opioid addiction treatment Suboxone. The settlement, disclosed on Saturday in a filing by lawyers for the health plans in federal court in Philadelphia, must still be approved by a judge. Indivior is still facing claims by drug wholesalers that bought Suboxone from the Virginia-based company directly, with a trial scheduled in October.

United-states , New-york , Philadelphia , Pennsylvania , Washington , Virginia , Alexia-garamfalvi , Mark-crossley , Brendan-pierson , Reuters , Us-centers-for-disease , Disease-control

Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims

* Indivior Reaches Agreement with States' Attorneys General and District of Columbia to Resolve Antitrust Multi-District Litigation Claims
Richmond, VA --- Indivior PLC , a leading addiction... | June 5, 2023

United-states , United-kingdom , Pennsylvania , District-of-columbia , Tim-owens , Jason-thompson , Mark-crossley , Ben-atkins , United-states-district-court , Indivior-inc , Eastern-district-of-pennsylvania-the-court , Drug-administration

Opioid-Treatment Maker Settles With Ohio for $6 Million

More than most states, Ohio has been ravaged by overdoses due to opioids and other drugs.

District-of-columbia , United-states , Colorado , Arkansas , South-carolina , Connecticut , Iowa , Kansas , Rhode-island , Kentucky , Maine , Georgia

Indivior's Overdose-Reversal Nasal Spray Gets FDA Approval

By Elena Vardon

Indivior on Tuesday said the U.S. Food and Drug Administration has approved its nasal spray OPVEE for emergency treatment for opioid overdose.

The U.K. pharmaceutical... | May 23, 2023

Mark-crossley , Elena-vardon , Drug-administration , Executive-mark-crossley , Dow-jones , Indivior-plc-stock-exchange , Ews , Nformation , Ress-release , Y , Lena , Ardon